Table 2 Percentage of drug recommendations based on outcome
From: Surrogate outcomes: experiences at the Common Drug Review
Factor | Final outcome¥(n = 26) | Other outcome* (n = 62) | Surrogate outcome§(n = 68) |
|---|---|---|---|
DNL recommendation | 15/26 (58%) | 32/62 (52%) | 28/68 (41%) |
Statement of clinical uncertainty | 13/26 (50%) | 36/62 (58%) | 26/68 (38%) |
Price only economic factor | 12/26 (46%) | 30/62 (48%) | 34/68 (50%) |
Economic considered | 11/26 (42%) | 29/62 (47%) | 28/68 (41%) |
Price greater than comparators | 19/26 (73%) | 30/62 (48%) | 29/68 (43%) |